HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Hsing Lin Selected Research

2- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acid

2/2008A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Hsing Lin Research Topics

Disease

12Neoplasms (Cancer)
10/2021 - 02/2008
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019 - 07/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 06/2008
1Epilepsy (Aura)
10/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2021
1Severe Acute Respiratory Syndrome
01/2020
1Feline Infectious Peritonitis
01/2020
1Leukemia
01/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2019
1Carcinoma (Carcinomatosis)
05/2018
1Colonic Neoplasms (Colon Cancer)
07/2013
1Hepatocellular Carcinoma (Hepatoma)
05/2013
1Infections
04/2011
1Carcinogenesis
01/2011
1Lung Neoplasms (Lung Cancer)
07/2010
1Mouth Neoplasms (Oral Cancer)
02/2008
1Diabetes Mellitus
02/2008
1Ataxia Telangiectasia (Louis Bar Syndrome)
02/2008

Drug/Important Bio-Agent (IBA)

7Phosphotransferases (Kinase)IBA
01/2020 - 07/2010
4Aurora KinasesIBA
10/2021 - 01/2011
3Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2011
3ErbB Receptors (EGF Receptor)IBA
11/2019 - 06/2008
2Aurora Kinase AIBA
10/2021 - 05/2013
2Antiviral Agents (Antivirals)IBA
01/2020 - 04/2011
2QuinazolinesIBA
01/2020 - 12/2016
2tyrosine receptor (receptor, tyrosine)IBA
12/2019 - 05/2014
1Mesylates (Mesylate)IBA
10/2021
1Aurora Kinase BIBA
10/2021
1Oncogene Proteins (Oncogene Protein)IBA
10/2021
1Celecoxib (Celebrex)FDA Link
01/2020
1Tolcapone (Tasmar)FDA Link
01/2020
1GemcitabineFDA Link
01/2020
1HhAntag691IBA
01/2020
1bedaquiline (R207910)IBA
01/2020
1Clofazimine (Lamprene)FDA Link
01/2020
1conivaptan (Vaprisol)FDA Link
01/2020
1brequinarIBA
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2019
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
12/2019
1Tyrosine Kinase InhibitorsIBA
12/2019
1fms-Like Tyrosine Kinase 3IBA
06/2015
1BPR1J-340IBA
01/2014
1VorinostatFDA Link
01/2014
1Histone Deacetylase InhibitorsIBA
01/2014
1Antineoplastic Agents (Antineoplastics)IBA
07/2013
11- (4- (2- ((6- (4- (2- (dimethylamino)ethoxy)phenyl)furo(2,3- d)pyrimidin- 4- yl)amino)ethyl)phenyl)- 3- phenylureaIBA
07/2013
1Fluorouracil (Carac)FDA LinkGeneric
01/2013
1Transcription Factors (Transcription Factor)IBA
06/2011
1Gefitinib (Iressa)FDA Link
06/2011
1BPR1K653IBA
01/2011
1Etoposide (VP 16)FDA LinkGeneric
02/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2008
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2008
1PPAR alphaIBA
02/2008
1PPAR-gamma AgonistsIBA
02/2008
1trioctyl phosphine oxide (TOPO)IBA
02/2008
12- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acidIBA
02/2008

Therapy/Procedure

9Therapeutics
01/2020 - 06/2008
1Oral Administration
10/2021
1Immunotherapy
10/2021
1Precision Medicine
11/2019
1Drug Therapy (Chemotherapy)
06/2015
1Transplantation
01/2013